The purpose of this study was to evaluate the use of a broad panel of antibodies used as diagnostic markers for @entity361 in uterine @entity242 . The expression of @entity2277 , @entity1325 / @entity1326 , @entity3960 ( @entity3960 ), @entity2283 , h-caldesmon, actin, @entity33451 , @entity2282 , @entity2279 , @entity469 , @entity2467 , factor VIII, HMB-45, and @entity2281 protein was studied in 397 uterine @entity242 . @entity3960 was positive in 90% of the @entity1822 and when combined with @entity2283 or h-caldesmon, a positivity of 96% and 92%, respectively, was achieved. Actin and @entity33451 were positive in 4 of 5 @entity980 . @entity6019 reacted positive with @entity2282 in 62 of 84 @entity5 and negative with h-caldesmon in 75 of 84 @entity5 . @entity2282 was the most frequent positive marker in @entity6020 . Most @entity5 markers stained negative in undifferentiated uterine @entity242 , but 12 of 21 @entity5 reacted positive for @entity3960 . A few focally HMB-45-positive cells were found within all @entity5 groups, except in @entity980 and @entity2967 . Endothelial markers, @entity2281 protein, and @entity2467 do not seem to be of any diagnostic value in uterine @entity242 . In conclusion, when immunohistochemistry is used diagnostically in uterine @entity242 , a broad panel of markers provides better information than reliance on a single antibody.

Diagnostic immunohistochemistry in uterine XXXX : a study of 397 cases.

@entity980 :: ('MESH:D012208', 'Disease') :: ['rhabdomyosarcomas'] @entity2283 :: ('1674', 'Gene') :: ['desmin'] @entity242 :: ('MESH:D012509', 'Disease') :: ['sarcoma', 'sarcomas'] @entity1326 :: ('6508', 'Gene') :: ['AE3'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'tumors'] @entity6020 :: ('MESH:D018195', 'Disease') :: ['adenosarcoma'] @entity469 :: ('968', 'Gene') :: ['CD68'] @entity2279 :: ('5175', 'Gene') :: ['CD31'] @entity2282 :: ('4311', 'Gene') :: ['CD10'] @entity1325 :: ('6521', 'Gene') :: ['AE1'] @entity6019 :: ('MESH:D018203', 'Disease') :: ['Endometrial stromal sarcomas'] @entity33451 :: ('4656', 'Gene') :: ['Myf4'] @entity1822 :: ('MESH:D007890', 'Disease') :: ['ordinary leiomyosarcomas'] @entity3960 :: ('MESH:D018235', 'Disease') :: ['smooth muscle actin', 'SMA'] @entity2277 :: ('7431', 'Gene') :: ['vimentin'] @entity2967 :: ('MESH:D005870', 'Disease') :: ['giant cell tumors'] @entity2467 :: ('3815', 'Gene') :: ['CD117'] @entity361 :: ('MESH:C535700', 'Disease') :: ['abdominal mesenchymal tumors'] @entity2281 :: ('6271', 'Gene') :: ['S-100']
@entity242 :: (MESH:D012509,Disease) :: ['sarcomas']
